ChemicalBook > CAS DataBase List > 4,4'-Diaminodiphenylsulfone

4,4'-Diaminodiphenylsulfone

Product Name
4,4'-Diaminodiphenylsulfone
CAS No.
80-08-0
Chemical Name
4,4'-Diaminodiphenylsulfone
Synonyms
DDS;DAPSONE;DADPS;DAPSON;Acedapsone;AVLOSULFON;4-AMINOPHENYL SULFONE;4,4'-SULFONYLDIANILINE;4-Aminophen;DIAMINODIPHENYLSULPHONE
CBNumber
CB0152851
Molecular Formula
C12H12N2O2S
Formula Weight
248.3
MOL File
80-08-0.mol
More
Less

4,4'-Diaminodiphenylsulfone Property

Melting point:
175-177 °C(lit.)
Boiling point:
511.7±35.0 °C(Predicted)
Density 
1.2701 (rough estimate)
vapor pressure 
0.004Pa at 25℃
refractive index 
1.5950 (estimate)
storage temp. 
2-8°C
solubility 
0.38g/l
form 
Crystalline Powder
pka
pKb 13.0(at 25℃)
color 
White to beige
PH
5.5-7.5 (H2O, 20℃)(saturated aqueous solution)
Water Solubility 
<0.1 g/100 mL at 20 ºC
Merck 
14,2822
BRN 
788055
BCS Class
4,2
Stability:
Stable. Combustible. Incompatible with strong oxidizing agents.
InChIKey
MQJKPEGWNLWLTK-UHFFFAOYSA-N
LogP
0.97 at 25℃
CAS DataBase Reference
80-08-0(CAS DataBase Reference)
NIST Chemistry Reference
Dapsone(80-08-0)
IARC
3 (Vol. 24, Sup 7) 1987
EPA Substance Registry System
Dapsone (80-08-0)
More
Less

Safety

Hazard Codes 
Xn
Risk Statements 
22
Safety Statements 
22
RIDADR 
3249
WGK Germany 
1
RTECS 
BY8925000
TSCA 
Yes
HazardClass 
6.1(b)
PackingGroup 
III
HS Code 
29051620
HS Code 
29309070
Hazardous Substances Data
80-08-0(Hazardous Substances Data)
Toxicity
LD50 orally in Rabbit: 1000 mg/kg LD50 dermal Rabbit > 4000 mg/kg
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H302Harmful if swallowed

H370Causes damage to organs

H373May cause damage to organs through prolonged or repeated exposure

H411Toxic to aquatic life with long lasting effects

Precautionary statements

P260Do not breathe dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P273Avoid release to the environment.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
8.21073
Product name
4,4′-Diaminodiphenyl sulfone
Purity
for synthesis
Packaging
5G
Price
$33.5
Updated
2024/03/01
Sigma-Aldrich
Product number
8.21073
Product name
4,4′-Diaminodiphenyl sulfone
Purity
for synthesis
Packaging
250g
Price
$107
Updated
2024/03/01
Sigma-Aldrich
Product number
46158
Product name
Dapsone
Purity
VETRANAL , analytical standard
Packaging
250mg
Price
$62.1
Updated
2024/03/01
Sigma-Aldrich
Product number
1164008
Product name
Dapsone
Purity
United States Pharmacopeia (USP) Reference Standard
Packaging
200mg
Price
$436
Updated
2024/03/01
Sigma-Aldrich
Product number
BP102
Product name
Dapsone
Purity
British Pharmacopoeia (BP) Reference Standard
Packaging
100MG
Price
$221
Updated
2023/06/20
More
Less

4,4'-Diaminodiphenylsulfone Chemical Properties,Usage,Production

Chemical Properties

Off -White Crystalline Solid

Originator

Avlosulfon,Ayerst,US,1957

Uses

An antibacterial used in the treatment of dermatitis herpetiformis

Uses

antibacterial, leprostatic, dermatitis herpetiformis suppressant

Uses

4,4'-diaminodiphenylsulfone be used for preparation polyimide and epoxy resin material.

Uses

Hardening agent in the curing of epoxy resins.

Definition

ChEBI: A sulfone that is diphenylsulfone in which the hydrogen atom at the 4 position of each of the phenyl groups is substituted by an amino group. It is active against a wide range of bacteria, but is mainly employed for its actions against Mycobacteriu leprae, being used as part of multidrug regimens in the treatment of all forms of leprosy.

Indications

Although dapsone (Avlosulfon) is most often used as an antimicrobial agent, it has important antiinflammatory properties in many noninfectious skin diseases. The mechanism of action of dapsone in skin disease is not clear.Most of the cutaneous diseases for which it is effective manifest inflammation and are characterized by an infiltration of neutrophils; the drug’s antiinflammatory effect may arise from its inhibition of intracellular neutrophil reactions mediated by myeloperoxidase and hydrogen peroxide or from its scavenging of reactive oxygen species, which inhibits inflammation.

Indications

Although dapsone (Avlosulfon) was once used in the treatment and prophylaxis of chloroquine-resistant P. falciparum malaria, the toxicities associated with its administration (e.g., agranulocytosis, methemoglobinemia, hemolytic anemia) have severely reduced its use. Occasionally dapsone has been added to the usual chloroquine therapeutic regimen for the prophylaxis of chloroquine-resistant P. falciparum malaria. It is also used in combination therapy for leprosy.

Manufacturing Process

p-Chloronitrobenzene is reacted with NaSO2C6H5NHCOCH3 to give as an intermediate, O2NC6H5SO2C6H5NHCOCH3 which is then reduced and deacetylated to give the product, dapsone. Alternatively, benzene and sulfuric acid react to give phenyl sulfone which is nitrated, then reduced to give dapsone.

brand name

Hansolar (ParkeDavis).

Therapeutic Function

Antibacterial (leprostatic)

Synthesis Reference(s)

Synthesis, p. 640, 1981 DOI: 10.1055/s-1981-29557

Antimicrobial activity

Dapsone is active against many bacteria and some protozoa. Fully susceptible strains of M. leprae are inhibited by a little as 0.003 mg/L. It is predominantly bacteristatic. Resistance is associated with mutations in the folP1 gene involved in the synthesis of para-aminobenzoic acid.

Acquired resistance

Resistance to high levels is acquired by several sequential mutations. As a result of prolonged use of dapsone monotherapy, acquired resistance emerged in patients with multibacillary leprosy in many countries. Initial resistance also occurs in patients with both paucibacillary and multibacillary leprosy. Thus, leprosy should always be treated with multidrug regimens. Resistance of M. leprae to dapsone (and other anti-leprosy drugs) may now be determined by use of DNA microarrays.

General Description

Odorless white or creamy white crystalline powder. Slightly bitter taste.

Air & Water Reactions

Sensitive to oxidation and light. Insoluble in water.

Reactivity Profile

4,4'-Diaminodiphenylsulfone can neutralize acids in exothermic reactions to form salts plus water. May be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen is generated in combination with strong reducing agents, such as hydrides. Incompatible with strong oxidizing agents. Also incompatible with epoxy resins under uncontrolled conditions .

Fire Hazard

4,4'-Diaminodiphenylsulfone is probably combustible.

Pharmaceutical Applications

The most effective of a number of sulfonamide derivatives to be tested against leprosy. The dry powder is very stable. It is only slightly soluble in water.

Pharmacokinetics

Oral absorption: >90%
Cmax 100 mg oral: c. 2 mg/L after 3–6 h
Plasma half-life: 10–50 h
Plasma protein binding: c. 50%
It is slowly but almost completely absorbed from the intestine and widely distributed in the tissues, but selectively retained in skin, muscle, kidneys and liver. It is metabolized by N-oxidation and also by acetylation, which is subject to the same genetic polymorphism as isoniazid. The elimination half-life is consequently very variable, but on standard therapy the trough levels are always well in excess of inhibitory concentrations. It is mostly excreted in the urine: in the unchanged form (20%), as N-oxidation products (30%) and as a range of other metabolites.

Clinical Use

Dapsone (4,4 -sulfonylbisbenzeneamine; 4,4 -sulfonyldianiline;p,p -diaminodiphenylsulfone; or DDS [Avlosulfon])occurs as an odorless, white crystalline powder that is veryslightly soluble in water and sparingly soluble in alcohol.The pure compound is light stable, but traces of impurities,including water, make it photosensitive and thus susceptibleto discoloration in light. Although no chemical change is detectablefollowing discoloration, the drug should be protectedfrom light.
Dapsone is used in the treatment of both lepromatous andtuberculoid types of leprosy. Dapsone is used widely for allforms of leprosy, often in combination with clofazimine andrifampin. Initial treatment often includes rifampin with dapsone,followed by dapsone alone. It is also used to preventthe occurrence of multibacillary leprosy when given prophylactically.Dapsone is also the drug of choice for dermatitis herpetiformisand is sometimes used with pyrimethamine for treatmentof malaria and with trimethoprim for PCP.
Serious side effects can include hemolytic anemia,methemoglobinemia, and toxic hepatic effects. Hemolyticeffects can be pronounced in patients with glucose-6-phosphatedehydrogenase deficiency. During therapy, all patientsrequire frequent blood counts.

Clinical Use

Dapsone is approved for the treatment of an autoimmune blistering skin disease, dermatitis herpetiformis. This intensely pruritic eruption is characterized histologically by a dense dermal infiltration of neutrophils and subepidermal blisters. Other skin diseases in which dapsone is helpful are linear immunoglobulin A (IgA) dermatosis, subcorneal pustular dermatosis, leukocytoclastic vasculitis, and a variety of rarer eruptions in which neutrophils predominate, including some forms of cutaneous lupus erythematosus.

Clinical Use

Leprosy (multidrug regimens)
Prophylaxis of malaria, treatment of chloroquine-resistant malaria (in combination with pyrimethamine)
Prophylaxis of toxoplasmosis (in combination with pyrimethamine)
Prophylaxis (monotherapy) and treatment (in combination with trimethoprim) of Pneumocystis jirovecii pneumonia
Dermatitis herpetiformis and related skin disorders

Side effects

Although usually well tolerated at standard doses, gastrointestinal upsets, anorexia, headaches, dizziness and insomnia may occur. Less frequent reactions include skin rashes, exfoliative dermatitis, photosensitivity, peripheral neuropathy (usually in non-leprosy patients), tinnitus, blurred vision, psychoses, hepatitis, nephrotic syndrome, systemic lupus erythematosus and generalized lymphadenopathy.
The term ‘dapsone syndrome’ is applied to a skin rash and fever occurring 2–8 weeks after starting therapy and sometimes accompanied by lymphadenopathy, hepatomegaly, jaundice and/or mononucleosis.
Blood disorders include anemia, methemoglobinemia, sulfhemoglobinemia, hemolysis (notably in patients with glucose- 6-phosphate dehydrogenase deficiency), mononucleosis, leukopenia and, rarely, agranulocytosis. Severe anemia should be treated before patients receive dapsone.
The incidence of adverse reactions declined in the 1960s but reappeared around 1982 when multidrug therapy was introduced, and may represent an unexplained interaction with rifampicin.

Safety Profile

Poison by ingestion, intraperitoneal, and subcutaneous routes. Human systemic effects by ingestion: agranulocytosis, change in tubules and other kidney changes, cyanosis, effect on joints, hemolysis with or without anemia, jaundice, methemoglobinemiacarboxyhemoglobinemia, retinal changes, somnolence. Experimental reproductive effects. Can cause hepatitis, dermatitis, and neuritis. Questionable carcinogen with experimental carcinogenic and neoplastigenic data. Human mutation data reported. Used in leprosy treatment and veterinary medicine. When heated to decomposition it emits very toxic fumes of NOx and SOx. See also SULFONATES.

Synthesis

Dapsone, 4,4-diaminodiphenylsulfone (34.2.3), is synthesized from either 4-chloronitrobenzene or from the sodium salt of 4-acetamidobenzenesulfonic acid. Reacting 4-chloronitrobenzene with sodium sulfide gives 4,4-dinitrodiphenylthioester (34.2.1), and oxidation of the sulfur atom in this compound using potassium dichromate in sulfuric acid gives 4,4-dinitrodiphenylsulfone (34.2.2). Reduction of the nitro group in the resulting compound using tin dichloride in hydrochloric acid makes the desired dapsone.
It has also been suggested to reduce the nitro group to an amino group, protect it with an acetyl protection, oxidize the sulfur atom to a sulfone using potassium dichromate, and then remove the protective acetyl group by hydrolysis.

Another way of the synthesis of dapsone begins with 4-acetamidobenzenesulfonic acid, which is reacted with 4-chloronitrobenzene at high temperatures to give 4-acetamido-4- nitrodiphenylsulfone (34.2.4). Reducing the nitro group in this compound with tin dichloride in hydrochloric acid along with the simultaneous hydrolysis of the acetyl group under the reaction conditions gives the desired dapsone.

Drug interactions

Potentially hazardous interactions with other drugs
Antivirals: increased risk of ventricular arrhythmias with saquinavir - avoid.

Metabolism

Dapsone undergoes enterohepatic recycling. Dapsone is acetylated to monoacetyldapsone, the major metabolite, and other mono and diacetyl derivatives. Acetylation shows genetic polymorphism. Hydroxylation is the other major metabolic pathway resulting in hydroxylamine dapsone, which may be responsible for dapsoneassociated methaemoglobinaemia and haemolysis. Dapsone is mainly excreted in the urine, only 20% of a dose as unchanged drug.

4,4'-Diaminodiphenylsulfone Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

4,4'-Diaminodiphenylsulfone Suppliers

Huangshi Jingsheng Biotechnology Co., Ltd.
Tel
17771199833; 17771199833
Email
351013952@qq.com
Country
China
ProdList
2583
Advantage
58
Hubei Chanmol Biotech Co., Ltd.
Tel
0711-3812399 18062309155
Email
156941107@qq.com
Country
China
ProdList
3003
Advantage
58
Hubei YiKangYuan Chemical Co., Ltd.
Tel
027-87182908 18064088908
Fax
027-87182900
Email
65824125@qq.com
Country
China
ProdList
91
Advantage
55
Hunan Zengda Biological Technology Co., LTD
Tel
18711085600
Email
1652923704@qq.com
Country
China
ProdList
4582
Advantage
58
Taizhou Huaxi Technology Co. LTD
Tel
0576-89164227 13105618688
Fax
0576-89164227
Email
18323010@qq.com
Country
China
ProdList
39
Advantage
58
Hubei Soren Technology Co., Ltd
Tel
0-13419562052 13419562052
Email
wwmlyb@163.com
Country
China
ProdList
2880
Advantage
58
Jinan Junhe Pharmaceutical Co., Ltd
Tel
13475558980
Email
644535754@qq.com
Country
China
ProdList
299
Advantage
58
Hubei Youyicheng Industrial Co., Ltd.
Tel
19521119694
Fax
86-027-87001826
Email
1572909019@qq.com
Country
China
ProdList
156
Advantage
58
Hubei Hongfuda Biotechnology Co., Ltd.
Tel
027-17340521416 18086404407
Email
2186239902@qq.com
Country
China
ProdList
67
Advantage
58
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
96815
Advantage
76
More
Less

View Lastest Price from 4,4'-Diaminodiphenylsulfone manufacturers

Watson Biotechnology Co.,Ltd
Product
4,4'-Diaminodiphenylsulfone 80-08-0
Price
US $65.00-40.00/kg
Min. Order
1kg
Purity
0.99
Supply Ability
20MT
Release date
2024-07-18
Hebei Zhuanglai Chemical Trading Co.,Ltd
Product
4, 4′-Diaminodiphenylsulfone 80-08-0
Price
US $180.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
20ton
Release date
2024-06-05
WUHAN FORTUNA CHEMICAL CO., LTD
Product
4,4'-Diaminodiphenylsulfone 80-08-0
Price
US $0.00/KG
Min. Order
1KG
Purity
98%min
Supply Ability
30tons/month
Release date
2023-02-08

80-08-0, 4,4'-DiaminodiphenylsulfoneRelated Search:


  • FREE SAMPLE NCV 4,4-DIAMINO DIPHENYL SULPHONE STD
  • 4,4′-Diaminodiphenyl sulfone 4,4′-Sulfonyldianiline 4-Aminophenyl sulfone DDS Bis(4-aminophenyl) sulfone DDS
  • 4,4'-Diaminodiphenyl sulfone for synthesis
  • BIS(P-AMINOPHENYL)SULFONE
  • AVLOSULFON
  • BIS(4-AMINOPHENYL) SULFONE
  • EPORAL
  • DISULONE
  • DUMITONE
  • DIPHENASONE
  • DDS
  • DADPS
  • DAPSON
  • DAPSONE
  • Dapsonum
  • CROYSULFONE
  • 4,4'-DDS
  • 4,4'-DIAMINODIPHENYL SULFONE
  • 4,4-DIAMINODIPHENYL SULFONE
  • 4,4'-DIAMINODIPHENYL SULPHONE
  • 4,4-DIAMINODIPHENYLSULPHONE
  • 4,4'-SULFONYLDIANILINE
  • 4,4'-SULFONYLBISBENZENEAMINE
  • 4-AMINOPHENYL SULONE
  • 4-AMINOPHENYL SULFONE
  • SULFONA-MAE
  • SULPHADIONE
  • TIMTEC-BB SBB003168
  • P-AMINOPHENYL SULFONE
  • NOVOPHONE
  • P,P'-SULFONYLDIANILINE
  • ,4’-diaminodiphenylsulfone
  • 1,1’-sulfonylbis(4-aminobenzene)
  • 1,1’-sulfonylbis[4-aminobenzene]
  • 1,1’-sulphonylbis(4-aminobenzene)
  • 1,1'-Sulfonylbis[4-aminobenzene]
  • 1,1'-Sulphonylbis(4-aminobenzene)
  • 1358F
  • 4,4’-dapsone
  • 4,4’-sulfonylbisaniline
  • 4,4’-sulfonylbisbenzamine
  • 4,4’-sulfonylbis-benzenamin
  • 4,4’-sulfonylbisbenzenamine
  • 4,4'-Sulfonyldianiline Neo-Atromid
  • 4,4'-Sulphonylbisbenzamine
  • 4,4'-Sulphonylbisbenzenamine
  • 4,4'-Sulphonyldianiline
  • 4-[(4-Aminophenyl)sulfonyl]phenylamine
  • 4-Aminophen
  • 4-Aminophenylsulphone
  • Acedapsone
  • Aniline, 4,4'-sulfonyldi-
  • aniline,4,4’-sulfonyldi-
  • Araldite HT
  • Avlosulfone
  • Avlosulphone
  • Benzenamine, 4,4'-sulfonylbis-
  • benzenamine,4,4’-sulfonylbis-